ABT vs OPAL · P/E 25, rev $44.33B vs P/E 26, rev $349.0M
Abbott Laboratories (ABT) versus OPAL Fuels Inc (OPAL) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
OPAL Fuels Inc (OPAL) is a utilities - regulated gas company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported OPAL revenue for 2025-12-31 was $349.0M. Net income was $36.4M. Revenue was up 16.3% from 2024-12-31 to 2025-12-31. OPAL currently screens at market cap $318.1M and trailing P/E 26.0.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. OPAL currently screens at market cap $318.1M and trailing P/E 26.0.
Not investment advice. Open the ABT and OPAL stock pages for the full models.
Not investment advice.